The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis

OBJECTIVES: To investigate changes in BMD in RA patients receiving 3-year biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) or conventional synthetic DMARD (csDMARD). METHODS: Patients with RA were recruited from September 2014 until March 2019. Clinical characteristics...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Rheumatology (Oxford)
Asıl Yazarlar: Chen, Jia-Feng, Hsu, Chung-Yuan, Yu, Shan-Fu, Ko, Chi-Hua, Chiu, Wen-Chan, Lai, Han-Ming, Chen, Ying-Chou, Su, Yu-Jih, Cheng, Tien-Tsai
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Clinical Science
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449814/
https://ncbi.nlm.nih.gov/pubmed/31984422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez655
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller